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ABSTRACT Candida parapsilosis is an emerging non-albicans Candida species that
largely affects low-birth-weight infants and immunocompromised patients. Fungal
pathogenesis is promoted by the dynamic expression of diverse virulence factors,
with secreted proteolytic enzymes being linked to the establishment and progres-
sion of disease. Although secreted aspartyl proteases (Sap) are critical for Candida al-
bicans pathogenicity, their role in C. parapsilosis is poorly elucidated. In the present
study, we aimed to examine the contribution of C. parapsilosis SAPP genes SAPP1,
SAPP2, and SAPP3 to the virulence of the species. Our results indicate that SAPP1
and SAPP2, but not SAPP3, inﬂuence adhesion, host cell damage, phagosome-
lysosome maturation, phagocytosis, killing capacity, and cytokine secretion by hu-
man peripheral blood-derived macrophages. Puriﬁed Sapp1p and Sapp2p were also
shown to efﬁciently cleave host complement component 3b (C3b) and C4b proteins
and complement regulator factor H. Additionally, Sapp2p was able to cleave factor
H-related protein 5 (FHR-5). Altogether, these data demonstrate the diverse, signiﬁ-
cant contributions that SAPP1 and SAPP2 make to the establishment and progression
of disease by C. parapsilosis through enabling the attachment of the yeast cells to
mammalian cells and modulating macrophage biology and disruption of the com-
plement cascade.
IMPORTANCE Aspartyl proteases are present in various organisms and, among viru-
lent species, are considered major virulence factors. Host tissue and cell damage, hi-
jacking of immune responses, and hiding from innate immune cells are the most
common behaviors of fungal secreted proteases enabling pathogen survival and in-
vasion. C. parapsilosis, an opportunistic human-pathogenic fungus mainly threaten-
ing low-birth weight neonates and children, possesses three SAPP protein-encoding
genes that could contribute to the invasiveness of the species. Our results suggest
that SAPP1 and SAPP2, but not SAPP3, inﬂuence host evasion by regulating cell dam-
age, phagocytosis, phagosome-lysosome maturation, killing, and cytokine secretion.
Furthermore, SAPP1 and SAPP2 also effectively contribute to complement evasion.
KEYWORDS Candida parapsilosis, complement, host-pathogen interactions,
proteases, virulence
Candida infections are associated with a high socioeconomic impact and withmorbidity and mortality among infants, children, and the elderly worldwide (1, 2).
Among the non-albicans species, the incidence of infections caused by Candida parap-
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silosis is increasing worldwide and C. parapsilosis is currently the second or third most
common yeast species associated with invasive candidiasis in hospitals in Asian,
European, and South American countries (3). C. parapsilosis is commonly associated
with low-birth-weight neonate infections, invasive infections of hospitalized immuno-
compromised patients, and the receipt of parenteral nutrition or prolonged use of
intravascular devices (4). Despite its clinical signiﬁcance, the pathogenicity of C. parap-
silosis and its virulence factors and interactions with the host are still poorly understood
(5–7).
Aspartyl proteases are present in various organisms and are most active at acidic pH
(pH 1.9 to 4.0), share a catalytic apparatus, and cleave dipeptide bonds between two
hydrophobic amino acid residues (8). Fungal secreted aspartyl proteases are reported
to directly mediate virulence (9–13). C. parapsilosis possesses three aspartyl acid
protease-encoding genes, namely, SAPP1, SAPP2, and SAPP3. SAPP1 is duplicated in the
species’ genome (SAPP1a, SAPP1b) (14). A previously established Δ/Δsapp1a Δ/Δsapp1b
strain, lacking SAPP1, was shown to be hypersusceptible to human serum (HS), caused
attenuated host cell damage, and was phagocytosed and killed more efﬁciently by
human monocytes and macrophages than the wild-type strain (15). In another study
using reconstituted human oral epithelium (RHOE), levels of tissue damage caused by
C. parapsilosis were signiﬁcantly reduced in the presence of the Sapp inhibitor pepsta-
tin, further highlighting the role of secreted proteases in the species’ pathogenicity (16).
Upon superﬁcial infection, epithelial cells trigger an inﬂammatory response by
producing antimicrobial peptides and recruiting and activating innate immune cells,
including macrophages and neutrophils (17–19). Candida species can efﬁciently avoid
macrophage-mediated killing by host membrane rupture, secretion of proteases and
lipases, and induction of pyroptosis and by nutrient competition with the host (20–22).
Upon infection, the complement cascade also activates and plays a role in combating
pathogens via enhancing chemotaxis, phagocytosis, or T and B cell differentiation (23).
Pathogenic species have adopted several strategies to evade complement attack (24).
In particular, C. albicans either recruits complement regulator proteins on its surface or
cleaves complement proteins by secreting the proteases. C. parapsilosis can also bind
to human complement proteins; however, the effect of this binding has not been fully
resolved (25, 26).
To date, multiple studies have shown that C. albicans aspartyl proteases have
different abilities to damage epithelial cells, alter the host complement cascade, induce
macrophage chemotaxis or cytokine production, and mediate NLRP3 inﬂammasome
activation; less is known about the immune modulatory effects of aspartyl proteases in
C. parapsilosis (12, 27). Therefore, to elucidate the role of individual aspartyl proteases
in the virulence of C. parapsilosis, SAPP mutant strains were generated. Functional
characterization of these genes revealed that SAPP1 and SAPP2 (but not SAPP3) play an
important role in C. parapsilosis pathogenicity.
RESULTS
Generation and characterization of RI_SAPP1, RI_SAPP2, and RI_SAPP3 strains.
Aspartyl protease-encoding genes in C. albicans are associated with various physiolo-
gical and pathogenic roles. For instance, expression of SAPI to SAPIII has been associated
with the yeast form of this species and linked with phenotypic switching. Previously,
high levels of expression of SAPIV to SAPVI have been associated with the hyphal phase,
suggesting their assistance in pathogenicity development; however, their involvement
in virulence regulation is still debatable (14, 28, 29). The precise role of these genes in
virulence in C. parapsilosis is not well studied. Therefore, we sought to expand upon
prior work to further evaluate the biology of C. parapsilosis SAPP1 and to robustly
characterize the function of SAPP2 and SAPP3. To delineate the roles of C. parapsilosis
aspartyl proteases in virulence, we aimed to overexpress SAPP1, SAPP2, and SAPP3
genes individually under the control of a constitutive promoter (CaTDH3), integrated
into the C. parapsilosis neutral locus (CpNEUT5L) of the SAPP1-SAPP2-SAPP3 (sapp1/2/
3/) null mutant strain.
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All reintegrant mutant strains were established on the sapp1/2/3/ background to
avoid cross-interference from each Sapp. Mutant strains were conﬁrmed by colony PCR
and Southern blotting (data not shown).
Expression levels of SAPP genes in the reintegrant mutant strains were determined
using real-time PCR. Wild-type and mutant strains were cultivated in secreted-protease-
inducing medium (yeast carbon base [YCB] plus 0.2% bovine serum albumin [BSA]), and
the levels of expression of SAPP1, SAPP2, and SAPP3 were monitored after 48 h of
incubation. The levels of expression of genes SAPP1 and SAPP2 in reintegrant strains
RI_SAPP1 and RI_SAPP2 were similar to what was observed in the wild-type strains,
while the level of expression of SAPP3 was upregulated in the RI_SAPP3 strain by
4-fold (Fig. 1).
Next, we examined whether reintegration of SAPP genes altered the viability,
morphology, or bioﬁlm-forming ability of the mutant strains. No difference was ob-
served between the levels of growth of the mutants in either yeast extract-peptone-
dextrose (YPD) or YCB liquid medium at 30°C and the levels seen with the wild-type
strain (see Fig. S1A and B in the supplemental material), and the SAPP mutant strains
produced elongated pseudohyphae to the same extent as the reference strain in YPD
or RPMI medium supplemented with 10% fetal bovine serum (FBS) and spider liquid
medium (Fig. S2A to C). We observed no difference in colony morphologies (Fig. S3) or
in bioﬁlm-forming abilities (Fig. S4). We also tested the ability of the sapp1/2/3/
mutant to cope with stress by monitoring cell growth in the presence of several
stressors (Table S3). The sapp1/2/3/ mutant strain showed no differences in growth
in the presence of stressors (Fig. S5). These results demonstrate that the mutant strains
retained the physiological attributes and stress responses of the parental strain.
Semiquantitative detection of extracellular protease activity of SAPP mutant
strains. Candida secreted aspartyl proteases hydrolyze BSA present in agar plates. In
order to examine the secreted protease activity of the established strains, the wild-type
and SAPP mutant strains were spotted on plates containing YCB plus 0.2% BSA and,
following amido black staining, the width of the clearance zone was measured. The C.
parapsilosis wild-type strain showed a clear halo zone (7.3 mm in diameter) on BSA-
containing plates similar to the zones seen with strains RI_SAPP1 (5.78 mm) and
RI_SAPP2 (5.76 mm). The RI_SAPP3 and sapp1/2/3/ strains, however, showed no
proteolytic activity (Fig. 2). These results suggest that, in contrast to SAPP1 and SAPP2,
reintegration of SAPP3 does not restore the aspartyl protease activity of the sapp1/2/
3/ strain; thus, SAPP3 does not contribute to aspartyl protease secretion in this
species.
C. parapsilosis RI_SAPP3 and sapp1/2/3/ strains are sensitive to human
serum. To investigate the fungicidal effect of human serum on the examined strains,
FIG 1 mRNA expression of RI_SAPP1, RI_SAPP2, and RI_SAPP3 strains. Data represent fold changes in
expression levels of SAPP genes in RI_SAPP mutants compared to the corresponding genes in the
wild-type strain after growth in YCB plus 0.2% BSA medium. The ﬁgure represents data obtained from
triplicate experiments.
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yeast cells were cultivated in the presence of normal human serum (NHS) and CFU
determinations were performed at different time intervals. C. parapsilosis strains were
also grown in the presence of 20% heat-inactivated serum (HiS). The viability of the
RI_SAPP3 and sapp1/2/3/ strains was reduced signiﬁcantly after 18 and 24 h of
incubation in intact serum compared to the wild-type strain results, while the RI_SAPP1
and as RI_SAPP2 strains showed no sensitivity to NHS (Fig. 3A). However, no sensitivity
was observed after HiS treatment (Fig. 3B). These data suggest that Sapp1 and Sapp2
are involved in protection against human serum proteins but that Sapp3 is not
associated with this effect.
Secreted aspartyl proteases affect the adhesion capabilities of C. parapsilosis.
We further examined whether SAPP genes inﬂuence the adhesion properties of C.
parapsilosis by the use of biotic and abiotic surfaces. Results of the cell adhesion assays
showed that all three reintegrated mutant strains had signiﬁcantly reduced capabilities
of adhesion to polystyrene surfaces compared to the reference strain (Fig. 4A). The
highest reduction in adhesion was observed with the sapp1/2/3/ strain (approxi-
mately 40%), followed by RI_SAPP2 (25%), RI_SAPP3 (25%), and the RI_SAPP1 strain
(20%).
A signiﬁcant reduction in adhesion to cells of the TR146 human oral epithelial cell
line was observed with strain RI_SAPP3, while a moderate decrease was detected in the
case of the sapp1/2/3/ strain (Fig. 4B).
SAPP1 and SAPP2 partially restore the damage-causing capability of the sapp1/
2/3/ strain. The ability of the wild-type, SAPP mutant, and sapp1/2/3/ strains to
damage peripheral blood mononuclear cell-derived macrophages (PBMC-DMs) was
monitored by lactate dehydrogenase (LDH) release 24 and 48 h after coincubation. As
shown in Fig. 5, the wild-type, RI_SAPP1, and RI_SAPP2 strains induced levels of damage
similar to those seen with PBMC-DMs (7.779% 1.001% and 6.807% 1.642%, respec-
tively), whereas the RI_SAPP3 and sapp1/2/3/ strains caused signiﬁcantly less damage
(5.843% 0.5715% and 6.862% 1.340%, respectively) than the wild-type strain
(9.944% 0.6143%) after 24 h of coincubation. Differences between the examined
strains became more evident following 48 h of coincubation. Host cell damage was
least severe in macrophages infected with the RI_SAPP3 and sapp1/2/3/ strains
(11.28% 0.8304% and 13.95% 1.153%, respectively), followed by RI_SAPP2
(19.98% 1.238%) and RI_SAPP1 (23.04% 1.661), compared to that seen with the
wild-type strain (40.36% 0.6912%) (Fig. 5). These results suggest that SAPP1 and
SAPP2 (but not SAPP3) contribute to the killing of PBMC-DMs.
Macrophages phagocytose and kill RI_SAPP3 and sapp1/2/3/ mutants more
efﬁciently than wild-type and RI_SAPP1 and RI_SAPP2 cells. We ﬁrst examined the
FIG 2 The protease activity of wild-type, sapp1/2/3/, and RI_SAPP strains was examined by BSA degradation assay. (A) A total of
106 Candida cells were spotted on YCB plus 0.2% BSA solid plates and incubated at 30°C for 3 days. The width of the proteolytic halo
zone was determined by amido black staining. Images are representative of results from 3 independent repeated experiments. WT,
wild type. (B) The radius (in millimeters) of each clearance (or proteolytic) zone was also measured.
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phagocytic capacity of PBMC-DMs by ﬂuorescence-activated cell sorter (FACS) analysis.
Yeast cells were labeled with the ﬂuorescent dye Alexa Fluor 488 and coincubated with
PBMC-DMs for 2 h at 37°C in the presence of 5% CO2. Our results indicated that
PBMC-DMs ingested RI_SAPP3 and sapp1/2/3/ more efﬁciently than the wild-type
strain (Fig. 6). We also examined the yeast cell killing efﬁciency of PBMC-DMs by
comparing the recovered fungal CFU counts after coincubation. Our data showed that
PBMC-DMs were able to kill signiﬁcantly more RI_SAPP3 (50.39% 2.328%) and sapp1/
2/3/ (53.90% 2.262%) cells than the wild-type strain (36.14% 2.652%) and strains
RI_SAPP1 (36.72% 2.930%) and RI_SAPP2 (44.82% 3.598%) (Fig. 7).
Aspartyl proteases promote intracellular survival of C. parapsilosis by altering
phagosome-lysosome maturation. A previous study reported that Candida cells can
replicate and survive within macrophages, either by diverting the normal process of
phagosome maturation, causing physical damage, or by withstanding the hostile
environment of the mature phagosome-lysosome (30). Here, we aimed to examine if C.
parapsilosis aspartyl proteases inﬂuence phagosome-lysosome maturation in human
PBMC-DMs. We analyzed the phagosome-lysosome maturation after coincubating
pHrodo-stained Candida cells with PBMC-DMs for 2 h. Interestingly, PBMC-DMs infected
with the wild-type strain, mutant strain RI_SAPP1, and mutant strain RI_SAPP2 showed
FIG 3 Serum sensitivity assay. The growth of C. parapsilosis wild-type and mutant strains in 20% NHS (A)
and HiS (B) was examined by determination of CFUs at 0, 6, 24, and 48 h. Data were obtained from three
independent experiments. Differences between groups were considered statistically signiﬁcant at
P 0.05. *, P  0.05; **, P 0.01.
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a lower rate of phagosome-lysosome fusion (16.66% 0.5732%, 20.76% 0.7194%,
and 13.78% 1.216%, respectively) than was seen with RI_SAPP3 (29.52% 2.719%)
and sapp1/2/3/ (28.70% 2.025%), indicating that Sapp1 and Sapp2 (but not Sapp3)
may promote intracellular survival of C. parapsilosis in human macrophages (Fig. 8).
FIG 4 In vitro cell adhesion assay. The ability of the wild-type and mutant strains to adhere to
polystyrene surfaces (A) and to TR146 epithelial cells (B) was assayed. Results (means  standard errors
of the means [SEM]) were gained from at least three independent experiments. *, P 0.05; **, P 0.01;
***, P 0.002; ****, P 0.0001.
FIG 5 Damage-causing efﬁciency of wild-type and mutant strains by LDH release. Human PBMC-DMs
were infected with the C. parapsilosiswild-type strain or mutant strain RI_SAPP or sapp1/2/3/ for 24 and
48 h, and levels of LDH release were measured. The obtained data represent macrophages obtained from
six healthy donors. *, P 0.05; **, P 0.01; ***, P 0.002; ****, P 0.0001; ns, not signiﬁcant.
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C. parapsilosis Sapp proteins regulate the cytokine response of host macro-
phages. In order to examine if the cytokine responses triggered by the wild-type strain,
the RI_SAPP mutants, and strains sapp1/2/3/ differed signiﬁcantly, we stimulated
human PBMC-DMs for 24 h with each strain and measured interleukin-1 (IL-1), tumor
necrosis factor alpha (TNF-), IL-6, and IL-8 responses. The obtained results indicated
that PBMC-DMs stimulated with either the wild-type strain or the RI_SAPP1 and
RI_SAPP2 strains produced similar IL-1, IL-8, and TNF- levels. In contrast, macro-
phages stimulated with strain sapp1/2/3/ produced signiﬁcantly less IL-1 and IL-6
and moderately but not signiﬁcantly less IL-8 than the wild-type strain (Fig. 9). PBMC-
DMs stimulated with RI_SAPP3 produced signiﬁcantly lower IL-8 and moderately low
FIG 6 Phagocytosis of wild-type and RI_SAPP and sapp1/2/3/ mutant strains by human-blood-derived macrophages determined by ﬂow cytometry. Human
PBMC-DMs were coincubated individually with Alexa Fluor 488-labeled fungal strains at 37°C for 2 h. Fungal cell-containing macrophages (phago) were
identiﬁed by ﬂow-cytometry and the percentage of phagocytosis was determined. Data were obtained from ﬁve independent experiments. *, P 0.05.
FIG 7 Killing of C. parapsilosis strains by human PBMC-DMs. Human PBMC-DMs were coincubated with
C. parapsilosis wild-type and sappmutant strains at 37°C for 3 h, and levels of yeast killing efﬁciency were
determined by CFU counting. Data were obtained using four healthy donors. *, P 0.05; **, P 0.01; ***,
P 0.002.
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IL-6 levels; however, no signiﬁcant differences were observed in the production of IL-1
and TNF- compared to wild type.
Sapp1p and Sapp2p have differential cleavage capacities against human com-
plement proteins. C. albicans secreted aspartyl proteases can cleave components of
human serum, including complement proteins (such as complement component 3b
[C3b], C4b, and C5 and the complement regulator FH) and other microbicidal plasma
proteins (31, 32). Therefore, to test if C. parapsilosis Sapp proteins are also able to cleave
human complement proteins, we incubated C3b and C4b and complement regulatory
proteins with the puriﬁed Sapp proteins. Our results indicated that the cleavage
efﬁciency of Sapp1p against C3b was higher (shown with stronger cleavage fragment)
than that of Sapp2p, which may suggest a difference in the substrate preferences of the
two proteases (Fig. 10A). Moreover, Sapp1p and Sapp2p were also able to cleave
human C4b (Fig. 10B). Puriﬁed C3b and C4b were incubated without Sapp proteins for
the same 3-h time period and used as negative controls; cleavage of C3b and cleavage
of C4b by factor I in the presence of its cofactors were included as positive controls. To
investigate if C. parapsilosis Sapp1p and Sapp2p can cleave complement regulators of
the FH protein family, we measured the capacity of Sapp1p and Sapp2p to degrade FH,
FHL-1, FHR-1, and FHR-5. Coincubation of Sapp1p or Sapp2p with FHL-1 or FHR-1
revealed that the proteases were not able to cleave these human complement proteins,
as visualized by Western blotting (Fig. S6). However, FH was cleaved by both fungal
proteases after 15 h of incubation. Interestingly, Sapp2p but not Sapp1p was able to
cleave FHR-5 at the early time point of 3 h, further indicating a difference in the
substrate preferences of C. parapsilosis Sapp proteins (Fig. 11).
Since attachment of opsonic complement proteins to pathogens enhances CR3-
mediated phagocytosis by macrophages and C. albicans cleaves CR3 and CR4 on
macrophages (31), we also tested whether C. parapsilosis Sapp1p and Sapp2p can
cleave complement receptors CR3 and CR4; however, we did not ﬁnd substantial
FIG 8 Phagosome-lysosome fusion following the uptake of wild-type and SAPP mutants. PBMC-DMs were infected with yeast cells labeled with pHrodo at a
1:5 ratio and were then incubated at 37°C for 2 h. Phagosome-lysosome fusion was then determined by ﬂow cytometry. Ch1, bright-ﬁeld image; Ch3, green
ﬂuorescence channel; Ch1/Ch3, merged image. Graph showing the extent of phagosome-lysosome fusion for the wild-type and mutant strains. n 5. **,
P 0.01; ***, P 0.002.
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differences in the levels of expression of CR3 and CR4 receptors on macrophages after
protease treatment (Fig. S7).
Fungal burden and Galleria mellonella survival. CFU recovery data show that
RI_SAPP1 produced CFU numbers similar to those seen with wild-type C. parapsilosis in
G. mellonella larvae (Fig. 12A). In contrast, the virulence of the other mutants was
attenuated compared to that of the parental strain.
Overall, larvae infected with wild-type and mutant strains showed no signiﬁcant
difference in survival after the 7 days of infection (Fig. 12B).
DISCUSSION
Aspartyl proteases are present in a diverse range of microorganisms and play a
crucial role in nutrition acquisition and pathogenesis. The presence of aspartyl pro-
FIG 9 Cytokine secretion by human-blood-derived macrophages in response to wild-type and SAPP mutant strains. Levels of IL-1 (upper left panel), TNF-
(upper right panel), IL-6 (lower left panel), and IL-8 (lower right panel) were measured by ELISA after stimulation of PBMC-DMs with the wild-type strain or a
SAPP mutant strain for 24 h. Data represent levels of cytokine production by macrophages obtained from 5 healthy donors. *, P 0.05.
FIG 10 Sapp-mediated cleavage of human complement components C3b and C4b. Sapp1p and Sapp2p
were incubated with the main opsonic human complement proteins C3b and C4b. After incubation, the
mixture was separated by SDS-PAGE and cleaved C3b (A) and C4b (B) fragments were identiﬁed by
Western blotting.
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teases in pathogenic Candida species and their absence in nonpathogenic fungal
species such as Saccharomyces cerevisiae suggests their role in pathogenesis. Previously,
we showed that C. parapsilosis /sapp1a, /sapp1b, and /sapp1a-//sapp1b
deletion mutant strains are less virulent than the wild-type strain, demonstrating that
FIG 11 Sapp-mediated cleavage of human complement regulators. Cleavage of FH (A) and FHR-5 (B) by Sapp1p
and Sapp2p was determined after 3h and 15 h of incubation.
FIG 12 Virulence of C. parapsilosis wild-type and SAPP mutant strains in G. mellonella. (A) Fungal burden
of G. mellonella larvae infected with the wild-type strain or a SAPP mutant strain. Larvae were incubated
at 30°C for 24 h. (B) Survival curves of G. mellonella infected with C. parapsilosis wild-type strain and sapp
mutant strains. The infected larvae were incubated at 30°C for 7 days. Four individual experiments were
performed using at least ﬁve larvae per round for CFU counting. Two individual experiments were
performed using 24 larvae per round for the survival assay. *, P 0.05; **, P 0.01; ****, P 0.0001.
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Sapp1p plays a role in pathogenesis regulation. To date, the roles of SAPP2 and SAPP3
in C. parapsilosis virulence have not been investigated. Therefore, in the present study,
we aimed to delineate their roles in pathogenicity using a secreted aspartyl protease-
deﬁcient strain (sapp1/2/3/) and mutant strains that express each SAPP gene indi-
vidually under the control of a constitutive promoter (pCaTDH3).
In C. albicans, secreted proteins play an important role in morphology and bioﬁlm
formation (33–36). Hence, we ﬁrst determined the corresponding effects of SAPP
proteins in C. parapsilosis. In contrast to C. albicans, C. parapsilosis SAPP proteins do not
affect either of these properties. SapII, SapV, and SapVI were previously reported to play
a role in tissue adhesion C. albicans in addition to their role in bioﬁlm formation (37).
Furthermore, C. albicans Sap1p, Sap2p, Sap3p, and Sap9p were previously reported to
be involved in adherence to epithelial cells (10, 38, 39). In the present study, we showed
that Sapp1p, Sapp2p, and Sapp3p in C. parapsilosis also contribute to adhesion,
although possibly to differing degrees.
As shown by examining the effect of cell wall-perturbing agents, disruption of the
SAPP genes did not affect the mutant strain’s survival, indicating that C. parapsilosis
aspartyl proteases do not inﬂuence the species’ ﬁtness and viability.
On the other hand, disruption of SAPP1 and SAPP2 but not SAPP3 resulted in serum
sensitivity. These results suggest that only the former two proteases are required for
serum survival in this species. This observation is consistent with a previous ﬁnding
according to which enhanced Sapp1p production was detected in C. parapsilosis cells
in the presence of serum albumin (28).
Pathogenic fungi have been previously reported to overcome the fungicidal effects
of human serum via actively secreting aspartyl proteases to neutralize proteins with
antimicrobial effects (15, 40). For instance, complement proteins have diverse functions
that include opsonization of microbes to facilitate phagocytosis, activation of cellular
responses, initiation of inﬂammation, and direct lysis of microbial cells (41, 42). The
protective effects of Sapp1p and Sapp2p mentioned above might be the result of their
ability to cleave complement components. Therefore, we further aimed to examine the
complement cleavage activity of puriﬁed Sapp1p and Sapp2p proteins. Complement
component 3 (C3) plays a central role in all three complement pathways. Following its
cleavage by C3 convertase, the resulting C3b fragment forms the C5 convertases that
are necessary for the progression of the complement cascade. Our results suggest that
C. parapsilosis is able to escape such complement-mediated attacks through the activity
of its secreted aspartyl proteases, as both Sapp1p and Sapp2p are able to efﬁciently
degrade the active complement C3b and C4b fragments required for convertase
functioning and opsonization, similarly to the degradation and thus inactivation in the
host mediated by serine protease factor I, a complement control protein (CCC).
FH and FHL-1 inhibit complement activation in the host but also do so when
sequestered from serum by pathogenic microbes as an immune escape mechanism. FH
and FHL-1 bind to microbial ligands through speciﬁc domains that are partially con-
served among other members of the FH protein family, i.e., the FHR proteins (43, 44).
FHRs were also reported previously to be involved in complement cascade regulation,
although this is a controversial issue (43, 45, 46). FHR-1 was reported to inhibit C5 and
the terminal pathway, whereas FHR-2 inhibits the alternative pathway and activation of
the terminal pathway. FHR-5 displays weak cofactor activity and inhibits the C3
convertase and was recently reported to inhibit C5 conversion (47–51). On the other
hand, FHR-1, FHR-4, and FHR-5 were shown to support alternative pathway activation
at the C3 level by binding C3b and allowing the formation of the C3 convertase (52–54).
Thus, FHRs—due to the presence of conserved domains—may competitively inhibit
FH/FHL-1 binding to microbes and enhance opsonization (50, 55). According to our
results, neither FHL-1 nor FHR-1 is cleaved by C. parapsilosis Sapp1p or Sapp2. Further-
more, a difference in substrate preference is also evident, as Sapp2p, but not Sapp1p,
is able to cleave FHR-5. The cleavage of FHR-5 but not FHL-1 and FHR-1 suggests that
Sapp2p presumably cleaves at locations near complement control protein (CCP) do-
mains 3, 4, 5, 6, and 7, which are absent in FHL-1 and FHR-1 but present in FHR-5 and
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FH, although further studies are needed to conﬁrm this hypothesis. These data suggest
that the secreted aspartyl proteases of this species show a substrate preference for
complement proteins involved in activation of the cascade, rather than for complement
control proteins (e.g., factor H family proteins).
C. albicans attachment and subsequent colonization are necessary to induce inﬂam-
matory responses in epithelial cells (56). Activation of epithelial cells also shapes the
responses of monocytes, macrophages, and other immune cells during a fungal
infection. Professional antigen-presenting cells such as macrophages connect the
innate and adaptive arms of the host’s immune responses by processing and present-
ing antigens to other effector cells and actively eliminating pathogens. Thus, we next
examined if disruption of any of the C. parapsilosis SAPP genes would have an effect on
macrophage activity. Our results indicate that human PBMC-DMs were able to phago-
cytose and eliminate sapp1/2/3/ and RI_SAPP3 cells more efﬁciently than the wild-
type and RI_SAPP1 or RI_SAPP2 strains.
The aspartyl proteases of C. albicans induce proinﬂammatory cytokine responses to
differing degrees. For instance, SapI, SapII, and SapVI signiﬁcantly induce IL-1, TNF-,
and IL-6 production, while SapIII is able to stimulate IL-1 and TNF- secretion (57).
Besides inducing low levels of host cell damage, the sapp1/2/3/ and RI_SAPP3 strains
also induced lower levels of proinﬂammatory cytokines (IL-1, IL-6, and IL-8) than the
parental and RI_SAPP1 or RI_SAPP2 strains. These results, together with the data
gathered from G. mellonella infection (an invertebrate model commonly applied to
mimic basic cellular and humoral mammal-like immune responses in vivo [58]), further
suggest differences in the contribution of C. parapsilosis Sapp proteins to virulence.
In conclusion, we demonstrated in the present study that C. parapsilosis Sapp
proteins did not affect formation of pseudohyphae or bioﬁlm. However, Sapp1p and
Sapp2p play roles in adhesion to epithelial cells and in host cell damage and might
promote survival within macrophages. Sapp-mediated cleavage of complement pro-
teins also suggests that C. parapsilosis might also interfere with human complement
attack. In summary, Sapp1p and Sapp2p, but not Sapp3p, are the major and fully
functional aspartyl proteases in C. parapsilosis that actively affect the species’ patho-
genicity.
MATERIALS AND METHODS
Strains and growth conditions. The strains used in the present study and their abbreviations are
listed in Table S1 in the supplemental material. Strains were cultured overnight in YPD broth at 30°C, with
shaking. Cells from overnight cultures were collected by centrifugation and washed twice with sterile 1
PBS (phosphate-buffered saline), and the number of cells was adjusted as indicated in descriptions of the
respective experiments. For growth assays and gene expression studies, the wild-type and mutant strains
were cultivated in YCB (yeast carbon base) medium supplemented with 0.2% BSA (bovine serum
albumin) at 30°C. Escherichia coli DH5 was grown in LB (Luria-Bertani broth) or on LB plates supple-
mented with ampicillin (0.1 mg/ml) for plasmid construction and propagation.
Generation of C. parapsilosis secreted aspartyl protease mutant strains. sapp1/2/3/ mutants
were generated as described previously (15) with minor modiﬁcations. Brieﬂy, 	500-bp upstream and
downstream regions of SAPP2 and SAPP3 were PCR ampliﬁed and cloned in the pSFS2a plasmid with a
recyclable NAT cassette. Further, the SAPP2 deletion cassette was introduced in the sapp1a sapp1b
deletion mutant strains to generate sapp1a sapp1b sapp2 mutants. Finally, the SAPP3 deletion
cassette was generated similarly to SAPP2, and sapp1a sapp1b sapp2 mutant strains were
transformed with the construct to generate the sapp1/2/3/ strain.
Mutant strains expressing the individual SAPP genes were generated using the SAPP1-SAPP2-SAPP3
(sapp1/2/3/) null mutant strain. Solely SAPP1-, SAPP2-, and SAPP3-expressing mutants were established
using a replacement cassette targeting the Neut5l locus and containing the respective SAPP open
reading frames (ORFs) under the control of the CaTDH3 constitutive promoter. In each case, nourseothri-
cin was used as a selection marker. C. parapsilosis strains were transformed by electroporation as
described previously (59). The transformants were conﬁrmed by colony PCR and Southern blot analysis.
Gene expression studies. Total RNA was isolated from C. parapsilosis wild-type cells grown in YCB
plus 0.2% medium for 48 h using a RiboPure RNA puriﬁcation kit according to the manufacturer’s
instructions. A 500-ng volume of RNA was subjected to reverse transcription using a RevertAid ﬁrst-
strand cDNA synthesis kit according to the protocol provided by the manufacturer. Quantitative PCR
(qPCR) was performed using the primers listed in Table S2. The ampliﬁcation conditions were as follows:
one cycle of denaturation for 3 min at 95°C; denaturation at 95°C for 10 s; 49 cycles of annealing at 60°C
for 30 s, and elongation at 65°C for 30 s; with a ﬁnal extension step at 72°C for 30 s. TUB4 was used as
an internal control.
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Functional studies of the generated mutant strains. Functional studies of the generated strains
were performed as described previously (55, 60). Detailed descriptions of growth analysis and assays
required to determine extracellular protease activity, formation of pseudohyphae, bioﬁlm formation,
adhesion capabilities, stress response, serum sensitivity, phagocytosis, and yeast cell killing are available
in the supplemental material.
Human epithelial cell lines (TR146). The human buccal epithelial squamous carcinoma TR146 cell
line was kindly provided by Julian Naglik, Kings College London, United Kingdom, and cultured as
described previously (61).
Isolation and differentiation of PBMCs. Human peripheral blood mononuclear cells (PBMCs) were
isolated from buffy coats of healthy donors by Ficoll Paque Plus (GE Healthcare) density gradient
centrifugation and used to produce macrophages as described previously (62).
Cell damage (lactate dehydrogenase activity) assay. LDH activity in cell culture supernatants was
measured at 24 or 48 h of postinfection using a cytotoxicity detection kit (LDH; Roche) according to the
manufacturer’s instructions. Macrophages were stimulated with C. parapsilosis wild-type, RI_SAPP, and
sapp1/2/3/ cells at a ratio of 1:5 (host cell/Candida cell) for 24 or 48 h or left untreated. During analysis,
the values corresponding to the levels of LDH activity measured in cultures containing yeast cells alone
were subtracted from the values measured in stimulated samples. Experiments were performed with
PBMC-DMs derived from six independent donors in triplicate experiments.
Phagolysosome fusion. Fusion of phagosomes-lysosomes after infection was assayed as described
previously (63). Both the phagocytosis and phagolysosome fusion assays were performed with PBMC-
DMs derived from ﬁve independent donors.
Cytokine measurements. PBMC-DMs were infected with 5 105 fungal cells, and supernatant was
collected after 24 h of incubation. Then, the concentrations of secreted IL-1, IL-6, IL-8, and TNF- in cell
culture supernatants were determined by the use of commercial enzyme-linked immunosorbent assay
(ELISA) kits (R&D Systems) according to the manufacturer’s instructions. The experiments were performed
with PBMC-DMs derived from the blood of at least ﬁve independent donors.
Puriﬁcation of Sapp1p and Sapp2p. Sapp1p and Sapp2p were puriﬁed as described previously (64,
65). Proteins were stored at –80°C until use.
Cleavage activity. The proteolytic activity of puriﬁed Sapp1p and Sapp2p (1 g each) was assayed
by incubating them with puriﬁed human complement proteins C3b, C4b, and factor H (FH) (Merck) or
with recombinant factor H-like protein 1 (FHL-1) (expressed and puriﬁed as described previously) (66) or
FHR-1 or FHR-5 (Novoprotein) for 3 h or 15 h at 37°C. Aliquots were taken at the indicated time points,
separated by SDS-PAGE, and analyzed by Western blotting. C3b was identiﬁed by the use of polyclonal
goat anti-human C3 (Calbiochem, Quidel) in combination with a horseradish peroxidase (HRP)-
conjugated goat antibody (DAKOCytomation). C4b was detected with a monoclonal anti-C4c antibody
(Quidel) and with HRP-conjugated goat anti-mouse Ig (Dako). To detect cleavage of FH, FHL-1, FHR-1, and
FHR-5, polyclonal goat anti-FH (Calbiochem, Merck), mouse monoclonal anti-FH (A254; from Quidel), and
polyclonal goat anti-FHR-5 (R&D System) and the corresponding HRP-conjugated secondary antibodies
rabbit anti-goat Ig and goat anti-mouse Ig (Dako) were used. In addition, cleavage of C3b and C4b by
the natural, complement-speciﬁc protease factor I in the presence of the cofactors factor H and C4BP
(Hyphen Biomed) was assayed to compare with the cleavage patterns generated by the Sapp proteases.
Galleria mellonella infection. Galleria mellonella larvae (TruLarv) (0.20 to 0.35 g) were purchased
from Biosystems Technology Ltd., Exeter, United Kingdom. Upon arrival, the larvae were handled and
injected with wild-type or mutant strains as described previously (55).
For CFU determination, larvae (0.25 to 0.30 g) were infected with 105 Candida cells/10 l and
sacriﬁced at 24 h postinfection and the fungal load of each individual larva was determined. Brieﬂy, each
larva was homogenized in 5 ml of PBS. The homogenate was plated on YPD plates and incubated at 30°C
for 2 days, and the colonies were counted.
To monitor survival, the larvae used in the infection experiments were infected with 106 Candida
cells/10 l and kept at 30°C for 7 days and larval death was monitored every day. Groups of 5 larvae were
used per strain with four experimental replicates for CFU and 24 larvae per strain with two experimental
replicates for survival.
Ethics statement. For PBMC isolation, blood was collected from healthy individuals. The Institutional
Human Medical Biological Research Ethics Committee of the University of Szeged gave approval for the
procedure and the respective consent documents. Healthy individuals provided written informed
consent. The experiments were performed in accordance with the guidelines and regulations of the
Ethics Committee of the University of Szeged, and the experimental protocols were approved by the
same institutional committee.
Statistical analysis. Unpaired t tests were used to determine differences between the group results
determined by adhesion assay, LDH assay, phagocytosis assay, killing assay, cytokine analysis, and CFU
data analysis. Mantel-Cox (log rank) tests were used for evaluation of survival data. Differences were
considered statistically signiﬁcant at P values of 0.05 (*, P 0.05; **, P 0.01; ***, P 0.001).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
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FIG S1, TIF ﬁle, 0.4 MB.
FIG S2, TIF ﬁle, 1.4 MB.
FIG S3, TIF ﬁle, 0.7 MB.
Candida parapsilosis Secreted Aspartyl Proteases
July/August 2019 Volume 4 Issue 4 e00484-19 msphere.asm.org 13
 o
n
 N
ovem
ber 11, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
FIG S4, TIF ﬁle, 0.2 MB.
FIG S5, TIF ﬁle, 0.7 MB.
FIG S6, TIF ﬁle, 1.6 MB.
FIG S7, TIF ﬁle, 0.7 MB.
TABLE S1, DOCX ﬁle, 0.02 MB.
TABLE S2, DOCX ﬁle, 0.02 MB.
TABLE S3, DOCX ﬁle, 0.02 MB.
ACKNOWLEDGMENTS
We thank Joshua D. Nosanchuk for critically reading the manuscript and for valuable
suggestions. We also thank Peter Horvath for providing us the sapp1/2/3/ mutant
strain for subsequent characterizations and Csaba Papp, Katalin Csonka, Erik Zajta, and
Tanmoy Chakraborty for assistance with the experiments.
D.K.S. was supported by the Stipendium Hungaricum Program (2015 to 2018). O.H.
and J.D. were supported by NPU project LO1302 from the Ministry of Education, Czech
Republic. M.J. was supported by the Institutional Excellence Program of the Ministry of
Human Capacities of Hungary (20460-3/2018/FEKUTSTRAT) and grant K125219. S.L. and
Z.B. were supported by the Hungarian National Science Fund (OTKA) grant K112011
and by the Hungarian Academy of Sciences. T.N., R.T., and A.G. were supported by
grants 20391-3/2018/FEKUSTRAT, NKFIH K 123952, and GINOP-2.3.2.-15-2016-00015.
A.G. was further funded by LP2018-15/2018.
We declare that the research was conducted in the absence of any commercial or
ﬁnancial relationships that could be construed as a potential conﬂict of interest.
REFERENCES
1. Falagas ME, Roussos N, Vardakas KZ. 2010. Relative frequency of albicans
and the various non-albicans Candida spp among candidemia isolates
from inpatients in various parts of the world: a systematic review. Int J
Infect Dis 14:e954–e966. https://doi.org/10.1016/j.ijid.2010.04.006.
2. Lockhart SR. 2014. Current epidemiology of Candida infection. Clin
Microbiol Newsl 36:131–136. https://doi.org/10.1016/j.clinmicnews.2014
.08.001.
3. Tóth R, Nosek J, Mora-Montes HM, Gabaldon T, Bliss JM, Nosanchuk JD,
Turner SA, Butler G, Vágvölgyi C, Gácser A. 2019. Candida parapsilosis:
from genes to the bedside. Clin Microbiol Rev 32:1–38.
4. van Asbeck EC, Clemons KV, Stevens DA. 2009. Candida parapsilosis: a
review of its epidemiology, pathogenesis, clinical aspects, typing and
antimicrobial susceptibility. Crit Rev Microbiol 35:283–309. https://doi
.org/10.3109/10408410903213393.
5. Gow NAR, van de Veerdonk FL, Brown AJP, Netea MG. 2012. Candida
albicans morphogenesis and host defence: discriminating invasion from
colonization. Nat Rev Microbiol 10:112–122. https://doi.org/10.1038/
nrmicro2711.
6. Naglik JR, Richardson JP, Moyes DL. 2014. Candida albicans pathogenic-
ity and epithelial immunity. PLoS Pathog 10:e1004257. https://doi.org/
10.1371/journal.ppat.1004257.
7. Araújo D, Henriques M, Silva S. 2017. Portrait of Candida species bioﬁlm
regulatory network genes. Trends Microbiol 25:62–75. https://doi.org/10
.1016/j.tim.2016.09.004.
8. Jaskolski M, Miller M, Mohana Rao JK, Gustchina A, Wlodawer A. 2015.
Elucidation of the structure of retroviral proteases: a reminiscence. FEBS
J 282:4059–4066. https://doi.org/10.1111/febs.13397.
9. Dutton LC, Jenkinson HF, Lamont RJ, Nobbs AH. 2016. Role of Candida
albicans secreted aspartyl protease SapIX in interkingdom bioﬁlm for-
mation. Pathog Dis 74:ftw005. https://doi.org/10.1093/femspd/ftw005.
10. Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, Tang J. 2013.
Candida albicans secreted aspartic proteases 4–6 induce apoptosis of
epithelial cells by a novel Trojan horse mechanism. FASEB J 27:
2132–2144. https://doi.org/10.1096/fj.12-214353.
11. Naglik JR, Challacombe SJ, Hube B. 2003. Candida albicans secreted
aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol
Rev 67:400–428. https://doi.org/10.1128/mmbr.67.3.400-428.2003.
12. Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L, Bistoni
F, Cassone A, Hube B, Vecchiarelli A. 2013. Secreted aspartic proteases of
Candida albicans activate the NLRP3 inﬂammasome. Eur J Immunol
43:679–692. https://doi.org/10.1002/eji.201242691.
13. Rasheed M, Battu A, Kaur R. 2018. Aspartyl proteases in Candida glabrata
are required for suppression of the host innate immune response. J Biol
Chem 293:6410–6433. https://doi.org/10.1074/jbc.M117.813741.
14. Rapala-Kozik M, Bochenska O, Zajac D, Karkowska-Kuleta J, Gogol M,
Zawrotniak M, Kozik A. 2018. Extracellular proteinases of Candida species
pathogenic yeasts. Mol Oral Microbiol 33:113–124. https://doi.org/10
.1111/omi.12206.
15. Horváth P, Nosanchuk JD, Hamari Z, Vágvölgyi C, Gácser A. 2012. The
identiﬁcation of gene duplication and the role of secreted aspartyl
proteinase 1 in Candida parapsilosis virulence. J Infect Dis 205:923–933.
https://doi.org/10.1093/infdis/jir873.
16. Silva S, Henriques M, Oliveira R, Azeredo J, Malic S, Hooper SJ, Williams
DW. 2009. Characterization of Candida parapsilosis infection of an in vitro
reconstituted human oral epithelium. Eur J Oral Sci 117:669–675.
https://doi.org/10.1111/j.1600-0722.2009.00677.x.
17. Williams DW, Jordan RPC, Wei X, Alves CT, Wise P, Wilson MJ, Lewis M.
2013. Interactions of Candida albicans with host epithelial surfaces. J
Oral Microbiol 5. https://doi.org/10.3402/jom.v5i0.2243.
18. Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler
AR, Ramani K, Mcgeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas
PS, Hube B, Naglik JR, Gaffen SL. 2017. Oral epithelial cells orchestrate
innate type 17 responses to Candida albicans through the virulence
factor candidalysin. Sci Immunol 2:eaam8834. https://doi.org/10.1126/
sciimmunol.aam8834.
19. Drummond RA, Gaffen SL, Hise AG, Brown GD. 2015. Innate defense
against fungal pathogens. Cold Spring Harb Perspect Med 5:a019620.
https://doi.org/10.1101/cshperspect.a019620.
20. Tucey TM, Verma J, Harrison PF, Snelgrove SL, Lo TL, Scherer AK,
Barugahare AA, Powell DR, Wheeler RT, Hickey MJ, Beilharz TH, Naderer
T, Traven A. 2018. Glucose homeostasis is important for immune cell
viability during Candida challenge and host survival of systemic fungal
infection. Cell Metab 27:988–1006.e7. https://doi.org/10.1016/j.cmet
.2018.03.019.
21. Kasper L, König A, Koenig P, Gresnigt MS, Westman J, Drummond RA,
Lionakis MS, Groß O, Ruland J, Naglik JR, Hube B. 2018. The fungal
peptide toxin Candidalysin activates the NLRP3 inﬂammasome and
causes cytolysis in mononuclear phagocytes. Nat Commun 9:4260.
https://doi.org/10.1038/s41467-018-06607-1.
Singh et al.
July/August 2019 Volume 4 Issue 4 e00484-19 msphere.asm.org 14
 o
n
 N
ovem
ber 11, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
22. Brown AJP, Gow NAR, Warris A, Brown GD. 2019. Memory in fungal
pathogens promotes immune evasion, colonisation, and infection.
Trends Microbiol 27:219–230. https://doi.org/10.1016/j.tim.2018.11.001.
23. Lubbers R, van Essen MF, van Kooten C, Trouw LA. 2017. Production of
complement components by cells of the immune system. Clin Exp
Immunol 188:183–194. https://doi.org/10.1111/cei.12952.
24. Rosbjerg A, Genster N, Pilely K, Garred P. 2017. Evasion mechanisms
used by pathogens to escape the lectin complement pathway. Front
Microbiol 8:1–7. https://doi.org/10.3389/fmicb.2017.00868.
25. Karkowska-Kuleta J, Zajac D, Bochenska O, Kozik A. 2015. Surfaceome of
pathogenic yeasts, Candida parapsilosis and Candida tropicalis, revealed
with the use of cell surface shaving method and shotgun proteomic
approach. Acta Biochim Pol 62:807–819. https://doi.org/10.18388/abp
.2015_1140.
26. Meri T, Hartmann A, Lenk D, Eck R, Würzner R, Hellwage J, Meri S, Zipfel
PF. 2002. The yeast Candida albicans binds complement regulators
factor H and FHL-1. Infect Immun 70:5185–5192. https://doi.org/10
.1128/iai.70.9.5185-5192.2002.
27. Bryan AM, Del Poeta M. 2016. Secretory aspartyl proteinases induce
neutrophil chemotaxis in vivo. Virulence 7:737–739. https://doi.org/10
.1080/21505594.2016.1206170.
28. Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. 1998.
The expression of the secreted aspartyl proteinases SapIV to SapVI from
Candida albicans in murine macrophages. Mol Microbiol 28:543–554.
https://doi.org/10.1046/j.1365-2958.1998.00815.x.
29. Dunkel N, Morschhäuser J. 2011. Loss of heterozygosity at an unlinked
genomic locus is responsible for the phenotype of a Candida albicans
sapIVΔ sapVΔ sapVIΔ mutant. Eukaryot Cell 10:54–62. https://doi.org/
10.1128/EC.00281-10.
30. Vylkova S, Lorenz MC. 2014. Modulation of phagosomal pH by Candida
albicans promotes hyphal morphogenesis and requires Stp2p, a regula-
tor of amino acid transport. PLoS Pathog 10:e1003995. https://doi.org/
10.1371/journal.ppat.1003995.
31. Svoboda E, Schneider AE, Sándor N, Lermann U, Staib P, Kremlitzka M,
Bajtay Z, Barz D, Erdei A, Józsi M. 2015. Secreted aspartic protease 2 of
Candida albicans inactivates factor H and the macrophage factor
H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18). Immunology
Lett 168:13–21. https://doi.org/10.1016/j.imlet.2015.08.009.
32. Poltermann S, Kunert A, Von Der Heide M, Eck R, Hartmann A, Zipfel PF.
2007. Gpm1p is a factor H-, FHL-1, and plasminogen-binding surface
protein of Candida albicans. J Biol Chem 282:37537–37544. https://doi
.org/10.1074/jbc.M707280200.
33. Gow NAR, Hube B. 2012. Importance of the Candida albicans cell wall
during commensalism and infection. Curr Opin Microbiol 15:406–412.
https://doi.org/10.1016/j.mib.2012.04.005.
34. Joo MY, Shin JH, Jang HC, Song ES, Kee SJ, Shin MG, Suh SP, Ryang DW.
2013. Expression of SAPV and SAPIX in Candida albicans bioﬁlms: com-
parison of bloodstream isolates with isolates from other sources. Med
Mycol 51:892–896. https://doi.org/10.3109/13693786.2013.824623.
35. Ghannoum M, Elteen KA. 1986. Correlative relationship between pro-
teinase production, adherence and pathogenicity of various strains of
Candida albicans. Med Mycol 24:407–413. https://doi.org/10.1080/
02681218680000621.
36. Navarro-Arias MJ, Defosse TA, Dementhon K, Csonka K, Mellado-Mojica
E, Dias Valério A, González-Hernández RJ, Courdavault V, Clastre M,
Hernández NV, Pérez-García LA, Singh DK, Vizler C, Gácser A, Almeida RS,
Noël T, López MG, Papon N, Mora-Montes HM. 2016. Disruption of
protein mannosylation affects Candida guilliermondii cell wall, immune
sensing, and virulence. Front Microbiol 7:1951. https://doi.org/10.3389/
fmicb.2016.01951.
37. Kumar R, Saraswat D, Tati S, Edgerton M. 2015. Novel aggregation
properties of Candida albicans secreted aspartyl proteinase sapVI medi-
ate virulence in oral candidiasis. Infect Immun 83:2614–2626. https://
doi.org/10.1128/IAI.00282-15.
38. Watts HJ, Cheah FS, Hube B, Sanglard D, Gow NA. 1998. Altered adher-
ence in strains of Candida albicans harbouring null mutations in secreted
aspartic proteinase genes. FEMS Microbiol Lett 159:129–135. https://doi
.org/10.1111/j.1574-6968.1998.tb12851.x.
39. Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, De Groot P, MacCa-
llum D, Odds FC, Schäfer W, Klis F, Monod M, Hube B. 2006.
Glycosylphosphatidylinositol-anchored proteases of Candida albicans
target proteins necessary for both cellular processes and host-
pathogen interactions. J Biol Chem 281:688–694. https://doi.org/10
.1074/jbc.M509297200.
40. Palmeira VF, Kneipp LF, Alviano CS, dos Santos A. 2006. Secretory
aspartyl peptidase activity from mycelia of the human fungal pathogen
Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors. Res
Microbiol 157:819–826. https://doi.org/10.1016/j.resmic.2006.07.003.
41. Noris M, Remuzzi G. 2013. Overview of complement activation and
regulation. Semin Nephrol 33:479–492. https://doi.org/10.1016/j.sem
nephrol.2013.08.001.
42. Arbore G, Kemper C, Kolev M. 2017. Intracellular complement  the
complosome  in immune cell regulation. Mol Immunol 89:2–9. https://
doi.org/10.1016/j.molimm.2017.05.012.
43. Józsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodríguez de
Córdoba S. 2015. Factor H-related proteins determine complement-
activating surfaces. Trends Immunol 36:374–384. https://doi.org/10.1016/j
.it.2015.04.008.
44. Józsi M. 2017. Factor H family proteins in complement evasion of microor-
ganisms. Front Immunol 8:571. https://doi.org/10.3389/ﬁmmu.2017.00571.
45. Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT. 2013. Complement
factor H related proteins (CFHRs). Mol Immunol 56:170–180. https://doi
.org/10.1016/j.molimm.2013.06.001.
46. Sánchez-Corral P, Pouw RB, López-Trascasa M, Józsi M. 2018. Self-
damage caused by dysregulation of the complement alternative
pathway: relevance of the factor H protein family. Front Immunol 9:1607.
https://doi.org/10.3389/ﬁmmu.2018.01607.
47. Zwarthoff SA, Berends ETM, Mol S, Ruyken M, Aerts PC, Józsi M, de Haas
CJC, Rooijakkers SHM, Gorham RD. 2018. Functional characterization of
alternative and classical pathway C3/C5 convertase activity and inhibi-
tion using puriﬁed models. Front Immunol 9:1691. https://doi.org/10
.3389/ﬁmmu.2018.01691.
48. McRae JL, Duthy TG, Griggs KM, Ormsby RJ, Cowan PJ, Cromer BA, Mc-
Kinstry WJ, Parker MW, Murphy BF, Gordon DL. 2005. Human factor
H-related protein 5 has cofactor activity, inhibits C3 convertase activity,
binds heparin and C-reactive protein, and associates with lipoprotein. J
Immunol 174:6250–6256. https://doi.org/10.4049/jimmunol.174.10.6250.
49. Hellwage J, Jokiranta TS, Koistinen V, Vaarala O, Meri S, Zipfel PF. 1999.
Functional properties of complement factor H-related proteins FHR-3
and FHR-4: binding to the C3d region of C3b and differential regulation
by heparin. FEBS Lett 462:345–352. https://doi.org/10.1016/s0014-5793
(99)01554-9.
50. Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, Schirmer S, Gropp
K, Enghardt T, Wallich R, Hälbich S, Mihlan M, Schlötzer-Schrehardt U,
Zipfel PF, Skerka C. 2009. Factor H-related protein 1 (CFHR-1) inhibits
complement C5 convertase activity and terminal complex formation.
Blood 114:2439–2447. https://doi.org/10.1182/blood-2009-02-205641.
51. Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper
MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C. 2013. Human
factor H-related protein 2 (CFHR2) regulates complement activation.
PLoS One 8:e78617. https://doi.org/10.1371/journal.pone.0078617.
52. Hebecker M, Józsi M. 2012. Factor H-related protein 4 activates comple-
ment by serving as a platform for the assembly of alternative pathway
C3 convertase via its interaction with C3b protein. J Biol Chem 287:
19528–19536. https://doi.org/10.1074/jbc.M112.364471.
53. Csincsi ÁI, Szabó Z, Bánlaki Z, Uzonyi B, Cserhalmi M, Kárpáti É, Tortajada
A, Caesar JJE, Prohászka Z, Jokiranta TS, Lea SM, Rodríguez de Córdoba
S, Józsi M. 2017. FHR-1 binds to C-reactive protein and enhances rather
than inhibits complement activation. J Immunol 199:292–303. https://
doi.org/10.4049/jimmunol.1600483.
54. Goicoechea de Jorge E, Lea SM, Daigo K, Caesar JJE, Csincsi ÁI, Zöldi M,
Pickering MC, Józsi M, Kopp A, Hamakubo T, Bánlaki Z, Uzonyi B,
Hebecker M. 2015. Factor H-related protein 5 interacts with pentraxin 3
and the extracellular matrix and modulates complement activation. J
Immunol 194:4963–4973. https://doi.org/10.4049/jimmunol.1403121.
55. Tóth R, Cabral V, Thuer E, Bohner F, Németh T, Papp C, Nimrichter L, Molnár
G, Vágvölgyi C, Gabaldón T, Nosanchuk JD, Gácser A. 2018. Investigation of
Candida parapsilosis virulence regulatory factors during host-pathogen in-
teraction. Sci Rep 8:1346. https://doi.org/10.1038/s41598-018-19453-4.
56. Richardson JP, Ho J, Naglik JR. 2018. Candida-epithelial interactions. J
Fungi (Basel) 4. https://doi.org/10.3390/jof4010022.
57. Pietrella D, Rachini A, Pandey N, Schild L, Netea M, Bistoni F, Hube B,
Vecchiarelli A. 2010. The inﬂammatory response induced by aspartic
proteases of Candida albicans is independent of proteolytic activity.
Infect Immun 78:4754–4762. https://doi.org/10.1128/IAI.00789-10.
58. Trevijano-Contador N, Zaragoza O. 2018. Immune response of Galleria
mellonella against human fungal pathogens. J Fungi (Basel) 5:3. https://
doi.org/10.3390/jof5010003.
Candida parapsilosis Secreted Aspartyl Proteases
July/August 2019 Volume 4 Issue 4 e00484-19 msphere.asm.org 15
 o
n
 N
ovem
ber 11, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
59. Gácser A, Trofa D, Schäfer W, Nosanchuk JD. 2007. Targeted gene deletion
in Candida parapsilosis demonstrates the role of secreted lipase in virulence.
J Clin Invest 117:3049–3058. https://doi.org/10.1172/JCI32294.
60. Németh T, Tóth A, Szenzenstein J, Horváth P, Nosanchuk JD, Grózer Z,
Tóth R, Papp C, Hamari Z, Vágvölgyi C, Gácser A. 2013. Characterization
of virulence properties in the C. parapsilosis sensu lato species. PLoS One
8:e68704. https://doi.org/10.1371/journal.pone.0068704.
61. Richardson JP, Mogavero S, Moyes DL, Blagojevic M, Krüger T, Verma AH,
Coleman BM, De La Cruz Diaz J, Schulz D, Ponde NO, Carrano G,
Kniemeyer O, Wilson D, Bader O, Enoiu SI, Ho J, Kichik N, Gaffen SL, Hube
B, Naglik JR. 2018. Processing of Candida albicans Ece1p is critical for
candidalysin maturation and fungal virulence. mBio 9:e02178-17.
https://doi.org/10.1128/mBio.02178-17.
62. Tóth A, Németh T, Csonka K, Horváth P, Vágvölgyi C, Vizler C, Nosanchuk
JD, Gácser A. 2014. Secreted Candida parapsilosis lipase modulates the
immune response of primary human macrophages. Virulence 5:555–562.
https://doi.org/10.4161/viru.28509.
63. Chakraborty T, Thuer E, Heijink M, Tóth R, Bodai L, Vágvölgyi C, Giera M,
Gabaldón T, Gácser A. 2018. Eicosanoid biosynthesis inﬂuences the
virulence of Candida parapsilosis. Virulence 9:1019–1035. https://doi
.org/10.1080/21505594.2018.1475797.
64. Dostál J, Brynda J, Hrusková-Heidingsfeldová O, Sieglová I, Pichová I,
Rezácová P. 2009. The crystal structure of the secreted aspartic protease
1 from Candida parapsilosis in complex with pepstatin A. J Struct Biol
27:160–165.
65. Hrus O, Hradilek M, Majer F, Havlı J. 2009. Two aspartic proteinases
secreted by the pathogenic yeast Candida parapsilosis differ in ex-
pression pattern and catalytic properties. Biol Chem 390:259 –
268.
66. Kopp A, Strobel S, Tortajada A, Rodríguez de Córdoba S, Sánchez-Corral
P, Prohászka Z, López-Trascasa M, Józsi M. 2012. Atypical hemolytic
uremic syndrome-associated variants and autoantibodies impair binding
of factor H and factor H-related protein 1 to pentraxin 3. J Immunol
189:1858–1867. https://doi.org/10.4049/jimmunol.1200357.
Singh et al.
July/August 2019 Volume 4 Issue 4 e00484-19 msphere.asm.org 16
 o
n
 N
ovem
ber 11, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
